CRIS Current Research Information System

GALLINELLA, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.645
AS - Asia 8.388
EU - Europa 6.061
AF - Africa 466
Continente sconosciuto - Info sul continente non disponibili 460
SA - Sud America 451
OC - Oceania 11
AN - Antartide 1
Totale 24.483
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.485
VN - Vietnam 2.331
CN - Cina 2.318
SG - Singapore 2.000
IT - Italia 1.499
GB - Regno Unito 1.359
DE - Germania 669
HK - Hong Kong 549
SE - Svezia 495
FR - Francia 410
IN - India 389
UA - Ucraina 369
RU - Federazione Russa 322
BR - Brasile 308
IE - Irlanda 205
KR - Corea 182
JP - Giappone 149
CH - Svizzera 139
ZA - Sudafrica 127
EE - Estonia 109
NL - Olanda 107
FI - Finlandia 91
CI - Costa d'Avorio 87
AR - Argentina 86
TG - Togo 85
CA - Canada 82
BG - Bulgaria 74
BD - Bangladesh 73
SC - Seychelles 61
IQ - Iraq 50
NG - Nigeria 42
TH - Thailandia 42
JO - Giordania 41
AT - Austria 39
IR - Iran 39
ID - Indonesia 37
BE - Belgio 35
PL - Polonia 34
MX - Messico 31
PH - Filippine 31
PK - Pakistan 31
ES - Italia 29
TW - Taiwan 28
TR - Turchia 20
SA - Arabia Saudita 16
CO - Colombia 14
KE - Kenya 13
EG - Egitto 12
RO - Romania 11
UZ - Uzbekistan 11
EC - Ecuador 10
GR - Grecia 10
LB - Libano 10
AU - Australia 9
CZ - Repubblica Ceca 9
JM - Giamaica 9
LT - Lituania 9
CM - Camerun 8
DO - Repubblica Dominicana 8
PE - Perù 8
RS - Serbia 8
CL - Cile 7
MY - Malesia 7
VE - Venezuela 7
HR - Croazia 6
MA - Marocco 6
OM - Oman 6
PY - Paraguay 6
CR - Costa Rica 5
SV - El Salvador 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
CY - Cipro 4
GT - Guatemala 4
HN - Honduras 4
HU - Ungheria 4
IL - Israele 4
SK - Slovacchia (Repubblica Slovacca) 4
YE - Yemen 4
DZ - Algeria 3
LV - Lettonia 3
PR - Porto Rico 3
TZ - Tanzania 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BY - Bielorussia 2
EU - Europa 2
KH - Cambogia 2
KZ - Kazakistan 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PT - Portogallo 2
SN - Senegal 2
TD - Ciad 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AQ - Antartide 1
Totale 24.004
Salva come PNG Salva come JPEG
Città #
Singapore 1.302
Southend 1.166
Ashburn 931
Fairfield 673
Chandler 589
Hong Kong 516
Dong Ket 514
San Jose 510
Ho Chi Minh City 466
Hefei 426
Hanoi 388
Seattle 342
Wilmington 327
Woodbridge 318
Bologna 298
Princeton 278
Houston 260
Council Bluffs 255
Dallas 253
Jacksonville 247
Ann Arbor 231
Beijing 229
Santa Clara 228
Cambridge 226
Dublin 203
Boardman 190
Seoul 161
Lauterbourg 144
Tokyo 130
Padova 129
Los Angeles 127
Westminster 127
New York 126
Bern 121
Nanjing 120
Milan 119
Berlin 99
Abidjan 87
Lomé 85
Buffalo 79
Helsinki 76
Sofia 72
Medford 71
Jinan 69
Haiphong 64
Saint Petersburg 63
Shenyang 63
Shanghai 56
Changsha 52
Da Nang 48
Zhengzhou 48
Tianjin 47
Hebei 46
Mülheim 46
Bengaluru 45
Rome 44
Redondo Beach 43
Amman 41
Parma 41
Nanchang 39
Abeokuta 37
Florence 37
San Diego 37
Buenos Aires 34
Guangzhou 33
Phoenix 33
São Paulo 33
Brussels 32
Bremen 31
Frankfurt am Main 31
Redwood City 31
Fremont 28
Hangzhou 28
Mahé 27
Biên Hòa 26
Toronto 26
Dearborn 25
Jiaxing 25
London 25
San Francisco 24
Verona 24
Yubileyny 23
Des Moines 22
Warsaw 22
Atlanta 21
Ningbo 21
Pune 21
Vienna 21
Bangkok 20
Hải Dương 20
Modena 20
Olalla 20
Taizhou 20
Turin 19
Paris 18
Shenzhen 18
Brooklyn 17
Johannesburg 17
Chicago 16
Munich 16
Totale 15.093
Salva come PNG Salva come JPEG
Nome #
Comparison of HPV sign Genotyping Test with INNO-LiPA HPV Genotyping Extra assay on histologic and cytologic cervical specimens 333
Antiviral activity of brincidofovir on parvovirus B19 293
Restriction Factors expression decreases in HIV-1 patients after cART 280
Parvovirus B19: Insights and implication for pathogenesis, prevention and therapy 262
Infezione da Parvovirus B19 nella donna in gravidanza, nel feto e nel neonato. 254
A new primer set improves the efficiency of competitive PCR-ELISA for the detection of B19 DNA 245
Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1 237
Targeting Parvovirus B19: antiviral strategies reviewed 236
Antiviral effect of cidofovir on parvovirus B19 replication 230
No G-Quadruplex Structures in the DNA of Parvovirus B19: Experimental Evidence versus Bioinformatic Predictions 228
Exploring parvovirus B19 pathogenesis and therapy among kidney transplant recipients: case report and review of literature 224
Next Generation Sequencing for the Analysis of Parvovirus B19 Genomic Diversity 222
Advances in the development of antiviral strategies against parvovirus B19 220
Paradoxical response to intravenous immunoglobulin in a case of Parvovirus B19-associated chronic fatigue syndrome 218
A Parvovirus B19 synthetic genome: sequence features and functional competence 218
The clinical use of parvovirus B19 assays: recent advances 216
Parvovirus B19 in pregnancy: possible consequences of vertical transmission. 213
Characterization of the human DNA gut virome across populations with different subsistence strategies and geographical origin 213
A Functional Minigenome of Parvovirus B19 211
Synthesis of 3-(Imidazo[2,1-b]thiazol-6-yl)-2H-chromen-2-one derivatives and study of their antiviral activity against parvovirus B19 205
Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus 203
Analysis of Parvovirus B19 DNA methylation status in experimental and natural infections. 201
A portable Microfluidic Device Based on Chemiluminescence Contact Imaging for detecting Parvovirus B19 in serum samples 200
Antiviral effect of Hydroxyurea on B19V replication 198
Analisi dell’integrazione del DNA di HPV16 in campioni cervicali, mediante PCR qualitativa e quantitativa 197
Analysis by real-time PCR of B19 virus replication and expression patterns in primary bone marrow and myeloblastoid cell lines 193
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 193
A loop mediated isothermal amplification (LAMP) assay to detect viral DNA in clinical specimens: BK polyomavirus and parvovirus B19 193
A proteomic approach to the analysis of B19 capsid proteins 191
On-chip LAMP-BART reaction for viral DNA real-time bioluminescence detection 191
Efficient treatment of paraffin-embedded cervical tissue for HPV DNA testing by HC-II and PCR assays 189
Ricerca e determinazione del carico virale di parvovirus B19 mediante tecnica di Real-time PCR calibrata 188
Parvovirus B19 Achievements and Challenges 188
Detection of viral DNA by isothermal NASBA amplification and chemiluminescence gene probe hybridization assay in a microfluidic cartridge 188
Epidemiology of Parvovirus B19 Infection In an Italian Metropolitan Area, 2012–2024: COVID‐19 Pre‐Pandemic, Pandemic and Post‐Pandemic Trends 187
Parvoviridae 185
Importin α/β-dependent nuclear transport of human parvovirus B19 nonstructural protein 1 is essential for viral replication 184
Gestational and fetal outcomes in B19 maternal infection: a problem of diagnosis 184
Analisi della competenza funzionale di cloni genomici di parvovirus B19 183
Comparative evaluation of an automated assay for parvovirus B19 antibody detection 183
Competitive PCR-ELISA protocols for the quantitative and the standardized detection of viral genomes. 182
Presenza e ruolo della metilazione dei dinucleotidi CpG nel DNA di parvovirus B19. 181
Mesenchymal stem cells are susceptible but non-permissive to B19V replication 181
Detection of HPV16 African variants and quantitative analysis of viral DNA methylation in oropharyngeal squamous cell carcinomas 178
Parvovirus B19 in Rheumatic Diseases 176
Ricerca del parvovirus B19 nello screening per la sicurezza degli emoderivati 176
Analisi della competenza funzionale di cloni genomici di parvovirus B19 per lo sviluppo di vettori virali 176
Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens. 176
Non-Permissive Parvovirus B19 Infection: A Reservoir and Questionable Safety Concern in Mesenchymal Stem Cells 175
Recurrent erythema in patients with long-term parvovirus B19 infection 175
A flow-FISH assay for the quantitative analysis of parvovirus B19 infected cells 175
Enhanced inhibition of parvovirus B19 replication by cidofovir in extendedly exposed erythroid progenitor cells 172
Parvovirus B19 infection during pregnancy and evaluation of fetal outcomes 170
Back from the past: Parvovirus B19 Genotype III DNA in the mummies of the Hermit Poor Clares of Fara in Sabina, Italy 168
Avermectins Inhibit Replication of Parvovirus B19 by Disrupting the Interaction Between Importin α and Non-Structural Protein 1 168
Parvovirus B19-derived fetal complications following gestational infection. 168
Parvovirus B19 DNA detection in serum samples employing a microfluidic device based on chemiluminescence contact imaging. 168
Parvovirus B19 Replication and Expression in Differentiating Erythroid Progenitor Cells 167
Peptide nucleic acid-based in situ hybridization assay for detection of parvovirus B19 nucleic acids 166
Hydroxyurea inhibits parvovirus B19 replication in erythroid progenitor cells 166
Rivelazione e caratterizzazione di varianti genotipiche di parvovirus B19 in sangue proveniente da unità trasfusionale 165
Analysis of the functional competence of genomic clones of Parvovirus B19 165
Analysis at single cell level of parvovirus B19 expression process by chemiluminescent microscope imaging assays 164
Simian parvovirus infection: a potential zoonosis 163
B19 in vitro infection of permissive systems: a quantitative analysis of virus replication and expression 161
Development of chemiluminescent assays for the quantitative detection and imaging of 5-bromo-2'deoxyuridine-labeled DNA in parvovirus B19-infected cells 161
Preliminary bioinformatic evaluation via Snakemake pipeline applied to 17th-18th century mummified specimens 160
Analisi funzionale del genoma di parvovirus B19 in due sistemi sperimentali: infezione in vitro e trasfezione con cloni ricombinanti 159
Analysis of splice junctions and polyadenylation sites of parvovirus B19 genome by a PCR-based approach 158
How does parvovirus B19 DNA achieve lifelong persistence in human cells? 157
Placental endothelial cells can be productively infected by Parvovirus B19 156
Calibrated real-time PCR for evaluation of parvovirus b19 viral load 156
Analisi del DNA di HPV 16 e degli mRNA E6/E7 in campioni citologici cervicali 155
Portable chemiluminescence multiplex biosensor for quantitative detection of three B19 DNA genotypes 155
Keeping pace with parvovirus B19 genetic variability: a multiplex genotype-specific quantitative PCR assay 154
Functional analysis and quantitative determination of the expression profile of human parvovirus B19 153
A loop-mediated isothermal amplification (LAMP) assay to detect parvovirus B19 DNA in clinical samples 153
Parvovirus B19 DNA Is Commonly Harboured in Human Skin. 152
Evidence of human bocavirus viremia in healthy blood donors. 152
Microfluidic cartridge with integrated array of amorphous silicon photosensors for chemiluminescence detection of viral DNA 152
Antiviral Activity of Cannabidiolic Acid and Its Methyl Ester against SARS-CoV-2 150
Analysis on Parvovirus B19 life cycle at single cell level by chemiluminescent imaging assays 150
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 150
Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays 148
Qualitative PCR-ELISA protocol for the detection and typing of viral genomes. 146
VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones 145
Parvovirus B19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease 145
Parvovirus B19 genome as a single, two-state replicative and transcriptional unit 144
Sviluppo di un dispositivo analitico miniaturizzato “Point-of-Care Testing” per la diagnosi di infezione da parvovirus B19 142
Reassembling in vitro the niche of Parvovirus B19 infection: a stem cell co-culture model 141
Implicazioni nella progressione della patologia cervicale 141
Tecniche di amplificazione real-time nella determinazione della carica virale: parvovirus B19 e papillomavirus umani 139
Gastrointestinal lesions in parvovirus B19 infection 139
Cellule progenitrici eritroidi ottenute da sangue periferico come sistema per lo studio della replicazione ed espressione di B19V 136
PNA-Based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 135
Prevention of iatrogenic transmission of B19 infection: different approaches to detect, remove or inactivate virus contamination 135
Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors 135
Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman 134
Bone marrow necrosis and fat embolism syndrome in sickle cell disease: Increased susceptibility of patients with non-SS genotypes and a possible association with human parvovirus B19 infection. 134
Antiviral effect of Cidofovir on B19V replication 134
Totale 18.015
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.162
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.162
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.210 0 124 119 193 205 126 55 169 89 197 492 441
2022/20232.561 282 345 128 316 157 168 77 122 423 50 232 261
2023/20241.222 46 127 75 147 101 252 84 94 56 70 83 87
2024/20253.210 152 490 320 233 420 173 282 100 62 159 190 629
2025/20268.004 755 1.070 901 633 870 410 664 219 1.397 543 347 195
2026/2027569 189 380 0 0 0 0 0 0 0 0 0 0
Totale 24.483